1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
    Neuronal Signaling
  3. iGluR
  4. Kainate Receptor Isoform

Kainate Receptor

Kainate receptors, or kainic acid receptors (KARs), are ionotropic receptors that respond to the neurotransmitter glutamate. They were first identified as a distinct receptor type through their selective activation by the agonist kainate, a drug first isolated from the algae Digenea simplex. They have been traditionally classified as a non-NMDA-type receptor, along with the AMPA receptor. KARs are less understood than AMPA and NMDA receptors, the other ionotropic glutamate receptors. Postsynaptic kainate receptors are involved in excitatory neurotransmission. Presynaptic kainate receptors have been implicated in inhibitory neurotransmission by modulating release of the inhibitory neurotransmitter GABA through a presynaptic mechanism.

Kainate Receptor 相关产品 (4):

目录号 产品名 作用方式 纯度
  • HY-15066
    CNQX Antagonist 99.65%
    CNQX (FG9065) 是一种有效的竞争性 AMPA /海藻酸酯受体 (AMPA/kainate receptor) 拮抗剂,IC50 分别为 0.3 μM 和 1.5 μM。CNQX 是一种竞争性的非 NMDA 受体拮抗剂。CNQX 会阻止大鼠恐惧增强的表达。
  • HY-15067
    DNQX

    二硝基喹酮

    Antagonist 99.26%
    DNQX (FG 9041),是一种喹恶啉衍生物,是一种选择性、强竞争性的非 NMDA 谷氨酸受体 (non-NMDA glutamate receptor) 拮抗剂 (对 AMPA、kainate 和 NMDA 受体的 IC50 分别为 0.5、2 和 40 μM)。
  • HY-103234A
    GYKI 52466 dihydrochloride Antagonist 99.38%
    GYKI 52466 dihydrochloride 是一种具有口服活性、高选择性和非竞争性的 AMPA/Kainate 受体拮抗剂,其 IC50 值分别为 7.5 和 11 μM。GYKI 52466 dihydrochloride 具有良好的血脑屏障通透性和抗惊厥作用,可用于帕金森病的研究。
  • HY-12499
    (S)-Willardiine

    尿嘧啶基丙氨酸

    Agonist 99.27%
    (S)-Willardiine是AMPA/kainate受体有效激动剂,EC50值为44.8uM。